Compliance and persistence: A comparison between typical and atypical antipsychotic treatment of schizophrenia patients

被引:0
|
作者
Liu, GG
Sun, SX
Zhao, Z
机构
[1] Univ N Carolina, Chapel Hill, NC USA
[2] Walgreens Hlth Serv, Deerfield, IL USA
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
关键词
D O I
10.1016/S1098-3015(10)64543-3
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A77 / A77
页数:1
相关论文
共 50 条
  • [21] Atypical antipsychotic drugs in the treatment of schizophrenia
    Meltzer, HY
    NORDIC JOURNAL OF PSYCHIATRY, 2001, 55 (02) : 86 - 86
  • [22] Prodromal schizophrenia and atypical antipsychotic treatment
    Kablinger, AS
    Freeman, AM
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2000, 188 (10) : 642 - 652
  • [23] Atypical antipsychotic medications and the treatment of schizophrenia
    Lewis, DA
    AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (02): : 177 - 179
  • [24] Atypical antipsychotic drugs in the treatment of schizophrenia
    Degner, D
    Rüther, E
    NERVENHEILKUNDE, 1998, 17 (10) : 472 - 479
  • [25] Association Between Persistence with Oral Atypical Antipsychotic Medications and Hospital and Emergency Department Utilization in Medicaid Patients with Schizophrenia
    Richards, Kristin
    Johnsrud, Michael
    Zacker, Christopher
    Sasane, Rahul
    PATIENT PREFERENCE AND ADHERENCE, 2024, 18 : 177 - 185
  • [26] A COMPARISON OF ATYPICAL AND TYPICAL NEUROLEPTICS ON GRAPHOMOTOR FUNCTIONS IN SCHIZOPHRENIA PATIENTS
    Nowinska, E.
    Raniszewska, I.
    Feit, J.
    Pasgreta, K.
    Lason, W.
    EUROPEAN PSYCHIATRY, 2012, 27
  • [27] A comparison of two doses of melperone, an atypical antipsychotic drug, in the treatment of schizophrenia
    Sumiyoshi, T
    Jayathilake, K
    Meltzer, HY
    SCHIZOPHRENIA RESEARCH, 2003, 62 (1-2) : 65 - 72
  • [28] A comparison of treatment-emergent diabetes among atypical and typical antipsychotic users
    Stafkey-Mailey, D. R.
    McCombs, J. S.
    Hay, J. W.
    EUROPEAN PSYCHIATRY, 2008, 23 : S148 - S149
  • [29] Compliance with atypical antipsychotic agents, suicide, and hospitalization rates amongst patients with schizophrenia in Quebec
    Ward, A.
    Ishak, K.
    Proskorovsky, I.
    Lam, A.
    Caro, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S266 - S266
  • [30] TREATMENT PERSISTENCE AND DISCONTINUATION RISK OF TYPICAL DEPOT AND ATYPICAL LONG-ACTING ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA IN POLAND
    Wierzbicka, N.
    Jakubczak, P.
    Krupa, D.
    Burski, J.
    Skrzekowska-Baran, I
    Czech, M.
    VALUE IN HEALTH, 2016, 19 (07) : A526 - A526